Recommendations from Thai stakeholders about protecting HIV remission (‘cure’) trial participants: report from a participatory workshop

作者：Holly L. Peay, Nuchanart Ormsby, Gail E. Henderson, Thidarat Jupimai, Stuart Rennie, Krittaecho Siripassorn, Kunakorn Kanchawee, Sinéad Isaacson, R. Jean Cadigan, Kriste Kuczynski, Udom Likhitwonnawut · 发表于：International Health · 年份：2020 · DOI：10.1093/inthealth/ihaa067 · 被引用次数：9 · 研究领域：Ethics in Clinical Research、HIV/AIDS Research and Interventions、HIV Research and Treatment

BACKGROUND: The social/behavioral HIV Decision-Making Study (DMS) assesses informed consent and trial experiences of individuals in HIV remission trials in Thailand. We convened a 1-d multi-stakeholder participatory workshop in Bangkok. We provide a meeting summary and reactions from DMS investigators. METHODS: Workshop members viewed de-identified interview excerpts from DMS participants. They deliberated on the findings and made recommendations regarding informed choice for remission trials. Notes and recordings were used to create a summary report, which was reviewed by members and refined. RESULTS: Workshop members' recommendations included HIV education and psychosocial support to establish the basis for informed choice, key trial information to be provided in everyday language, supportive decision-making processes and psychosocial care during and after the trial. Concerns included participant willingness to restart antiretrovirals after trial-mandated treatment interruption, unintended influence of the research team on decision-making and seemingly altruistic motivations for trial participation that may signal attempts to atone for stigmatized behavior. CONCLUSIONS: The workshop highlighted community perspectives and resulted in recommendations for supporting informed choice and psychosocial and physical health. These are the first such recommendations arising from a deliberative process. Although some elements are rooted in the Thai context, most are applicable across ...